• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

睾丸癌的流行病学考量及治疗趋势的最新进展

Update on epidemiologic considerations and treatment trends in testicular cancer.

作者信息

Woldu Solomon L, Bagrodia Aditya

机构信息

University of Texas Southwestern Medical Center, Dallas, Texas, USA.

出版信息

Curr Opin Urol. 2018 Sep;28(5):440-447. doi: 10.1097/MOU.0000000000000532.

DOI:10.1097/MOU.0000000000000532
PMID:30004908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6134403/
Abstract

PURPOSE OF REVIEW

We aim to give an overview of the epidemiology and treatment trends of testicular germ cell tumors (TGCTs), with an emphasis on recent trends.

RECENT FINDINGS

The incidence of TGCT appears to be increasing, particularly in developed countries, although the reasons are not well understood. There is evidence of racial differences in predisposition to TGCT, with white men having highest risk and men of African or Asian descent having lower risk. In the United States, the incidence of TGCT among Hispanics appears to be rising most quickly. A recent genomic analysis indicates there is no highly penetrant major TGCT susceptibility gene. Incorporation of multidisciplinary care has led to excellent long-term cure rates; however, access to care and insurance remains barriers in young men. Recent treatment trends have centered on maximizing oncologic outcomes while minimizing long-term morbidity.

SUMMARY

Emerging population-level data provide critical insight into the evolving demographics of TGCT, which may allow for elucidation of biologic and environmental determinants of TGCT. Further, identification of socioeconomic barriers to excellent clinical outcomes will allow for targeted interventions to patients with unique demographic and socioeconomic considerations. Treatment trend analyses suggest that the field is moving toward minimizing treatment-related morbidity.

摘要

综述目的

我们旨在概述睾丸生殖细胞肿瘤(TGCT)的流行病学和治疗趋势,重点关注近期趋势。

最新发现

TGCT的发病率似乎在上升,尤其是在发达国家,尽管其原因尚不清楚。有证据表明,TGCT易感性存在种族差异,白人男性风险最高,非洲或亚洲血统男性风险较低。在美国,西班牙裔人群中TGCT的发病率上升似乎最快。最近的基因组分析表明,不存在高 penetrance的主要TGCT易感基因。多学科护理的纳入带来了出色的长期治愈率;然而,对于年轻男性来说,获得护理和保险仍然是障碍。近期的治疗趋势集中在最大化肿瘤治疗效果的同时,最小化长期发病率。

总结

新出现的人群水平数据为TGCT不断变化的人口统计学提供了关键见解,这可能有助于阐明TGCT的生物学和环境决定因素。此外,识别影响卓越临床结果的社会经济障碍,将有助于针对具有独特人口统计学和社会经济特征的患者进行有针对性的干预。治疗趋势分析表明,该领域正在朝着最小化治疗相关发病率的方向发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0a5/6134403/2a185dde8bab/nihms-1502313-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0a5/6134403/bd40c17f4742/nihms-1502313-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0a5/6134403/d0e24b57354c/nihms-1502313-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0a5/6134403/2a185dde8bab/nihms-1502313-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0a5/6134403/bd40c17f4742/nihms-1502313-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0a5/6134403/d0e24b57354c/nihms-1502313-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0a5/6134403/2a185dde8bab/nihms-1502313-f0003.jpg

相似文献

1
Update on epidemiologic considerations and treatment trends in testicular cancer.睾丸癌的流行病学考量及治疗趋势的最新进展
Curr Opin Urol. 2018 Sep;28(5):440-447. doi: 10.1097/MOU.0000000000000532.
2
Recent trends in the incidence of testicular germ cell tumors in the United States.美国睾丸生殖细胞肿瘤发病率的近期趋势。
Andrology. 2015 Jan;3(1):13-8. doi: 10.1111/andr.288. Epub 2014 Oct 20.
3
Incidence of testicular germ cell tumors among US men by census region.按人口普查区域划分的美国男性睾丸生殖细胞肿瘤发病率。
Cancer. 2015 Dec 1;121(23):4181-9. doi: 10.1002/cncr.29643. Epub 2015 Aug 17.
4
Future of testicular germ cell tumor incidence in the United States: Forecast through 2026.美国睾丸生殖细胞肿瘤发病率的未来:至2026年的预测
Cancer. 2017 Jun 15;123(12):2320-2328. doi: 10.1002/cncr.30597. Epub 2017 Feb 27.
5
A mini-review of familial ovarian germ cell tumors: an additional manifestation of the familial testicular germ cell tumor syndrome.家族性卵巢生殖细胞肿瘤的小型综述:家族性睾丸生殖细胞肿瘤综合征的一种额外表现。
Cancer Epidemiol. 2009 Jul;33(1):31-6. doi: 10.1016/j.canep.2009.04.015. Epub 2009 May 30.
6
Increasing Incidence of Testicular Germ Cell Tumors among Racial/Ethnic Minorities in the United States.美国少数族裔人群中睾丸生殖细胞肿瘤发病率的上升。
Cancer Epidemiol Biomarkers Prev. 2020 Jun;29(6):1237-1245. doi: 10.1158/1055-9965.EPI-20-0107. Epub 2020 May 8.
7
Differences at Presentation and Treatment of Testicular Cancer in Hispanic Men: Institutional and National Hospital-based Analyses.西班牙裔男性睾丸癌在临床表现和治疗方面的差异:基于机构和全国医院的分析。
Urology. 2018 Feb;112:103-111. doi: 10.1016/j.urology.2017.08.059. Epub 2017 Dec 6.
8
Prospectively Identified Incident Testicular Cancer Risk in a Familial Testicular Cancer Cohort.家族性睾丸癌队列中前瞻性确定的偶发性睾丸癌风险
Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1614-21. doi: 10.1158/1055-9965.EPI-14-1240. Epub 2015 Aug 11.
9
Trends in testicular germ cell tumours by ethnic group in the United States.美国不同种族睾丸生殖细胞肿瘤的发病趋势。
Int J Androl. 2007 Aug;30(4):206-13; discussion 213-4. doi: 10.1111/j.1365-2605.2007.00795.x.
10
Testicular cancer in Hispanics: incidence of subtypes over time according to neighborhood sociodemographic factors in California.加利福尼亚州基于社区社会人口因素的时间趋势分析西班牙裔人群睾丸癌各亚型的发病率。
Cancer Causes Control. 2020 Aug;31(8):713-721. doi: 10.1007/s10552-020-01311-2. Epub 2020 May 21.

引用本文的文献

1
Understanding Sociodemographic Factors among Hispanics Through a Population-Based Study on Testicular Cancer in Mexico.通过墨西哥一项基于人群的睾丸癌研究了解西班牙裔的社会人口学因素。
J Racial Ethn Health Disparities. 2025 Feb;12(1):148-160. doi: 10.1007/s40615-023-01859-0. Epub 2023 Nov 14.
2
Clusterin suppresses invasion and metastasis of testicular seminoma by upregulating COL15a1.簇集素通过上调COL15a1抑制睾丸精原细胞瘤的侵袭和转移。
Mol Ther Nucleic Acids. 2021 Nov 10;26:1336-1350. doi: 10.1016/j.omtn.2021.11.004. eCollection 2021 Dec 3.
3
Between a Rock and a Hard Place: An Epigenetic-Centric View of Testicular Germ Cell Tumors.

本文引用的文献

1
Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study.基于顺铂的标准化疗后睾丸癌幸存者的累积发病率负担:一项多机构研究。
J Clin Oncol. 2018 May 20;36(15):1505-1512. doi: 10.1200/JCO.2017.77.0735. Epub 2018 Apr 4.
2
Disparities in Access and Regionalization of Care in Testicular Cancer.睾丸癌的治疗机会和区域化服务差距。
Clin Genitourin Cancer. 2018 Aug;16(4):e785-e793. doi: 10.1016/j.clgc.2018.02.014. Epub 2018 Feb 23.
3
Active Surveillance for Stage I Testicular Cancer: A Four-decade-old Experiment Proven Correct.
进退两难:以表观遗传学为中心的睾丸生殖细胞肿瘤观点
Cancers (Basel). 2021 Mar 25;13(7):1506. doi: 10.3390/cancers13071506.
4
Differential gene expression in cisplatin-resistant and -sensitive testicular germ cell tumor cell lines.顺铂耐药和顺铂敏感的睾丸生殖细胞肿瘤细胞系中的差异基因表达
Oncotarget. 2020 Dec 22;11(51):4735-4753. doi: 10.18632/oncotarget.27844.
5
lncRNA and Mechanisms of Drug Resistance in Cancers of the Genitourinary System.长链非编码RNA与泌尿生殖系统癌症中的耐药机制
Cancers (Basel). 2020 Aug 3;12(8):2148. doi: 10.3390/cancers12082148.
6
c-Src Recruitment is Involved in c-MET-Mediated Malignant Behaviour of NT2D1 Non-Seminoma Cells.c-Src 募集参与 c-MET 介导的 NT2D1 非精原细胞瘤细胞的恶性行为。
Int J Mol Sci. 2019 Jan 14;20(2):320. doi: 10.3390/ijms20020320.
I期睾丸癌的主动监测:一项历经四十年的实验被证明是正确的。
Eur Urol. 2018 Jun;73(6):908-909. doi: 10.1016/j.eururo.2018.03.001. Epub 2018 Mar 16.
4
Retroperitoneal Lymph Node Dissection as Primary Treatment for Metastatic Seminoma.腹膜后淋巴结清扫术作为转移性精原细胞瘤的主要治疗方法
Adv Urol. 2018 Feb 1;2018:7978958. doi: 10.1155/2018/7978958. eCollection 2018.
5
Large-scale Sequencing of Testicular Germ Cell Tumour (TGCT) Cases Excludes Major TGCT Predisposition Gene.大规模测序睾丸生殖细胞肿瘤(TGCT)病例排除主要 TGCT 易感性基因。
Eur Urol. 2018 Jun;73(6):828-831. doi: 10.1016/j.eururo.2018.01.021. Epub 2018 Feb 9.
6
Non-risk-adapted Surveillance for Stage I Testicular Cancer: Critical Review and Summary.非风险适应的 I 期睾丸癌监测:关键评价和总结。
Eur Urol. 2018 Jun;73(6):899-907. doi: 10.1016/j.eururo.2017.12.030. Epub 2018 Jan 12.
7
Current Practice Patterns Surrounding Fertility Concerns in Stage I Seminoma Patients: Survey of United States Radiation Oncologists.目前关于 I 期精原细胞瘤患者生育问题的实践模式:对美国放射肿瘤学家的调查。
J Adolesc Young Adult Oncol. 2018 Jun;7(3):292-297. doi: 10.1089/jayao.2017.0122. Epub 2018 Jan 16.
8
Fertility preservation for men with testicular cancer: Is sperm cryopreservation cost effective in the era of assisted reproductive technology?睾丸癌男性的生育力保存:在辅助生殖技术时代,精子冷冻保存是否具有成本效益?
Urol Oncol. 2018 Mar;36(3):92.e1-92.e9. doi: 10.1016/j.urolonc.2017.11.002. Epub 2017 Nov 21.
9
Differences at Presentation and Treatment of Testicular Cancer in Hispanic Men: Institutional and National Hospital-based Analyses.西班牙裔男性睾丸癌在临床表现和治疗方面的差异:基于机构和全国医院的分析。
Urology. 2018 Feb;112:103-111. doi: 10.1016/j.urology.2017.08.059. Epub 2017 Dec 6.
10
Impact of hospital case volume on testicular cancer outcomes and practice patterns.医院病例数量对睾丸癌治疗结果及诊疗模式的影响。
Urol Oncol. 2018 Jan;36(1):14.e7-14.e15. doi: 10.1016/j.urolonc.2017.08.024. Epub 2017 Sep 19.